Open AccessAbstract A097: Tubulysin ADC payloads: An antimitotic drug class that retains activity in multidrug resistant models
Author(s) -
Patrick Burke,
Joseph Z. Hamilton,
Thomas A. Pires,
Kim K. Emmerton,
Peter D. Senter,
Scott C. Jeffrey
Publication year - 2019
Publication title -
molecular cancer therapeutics
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-8514
pISSN - 1535-7163
DOI - 10.1158/1535-7163.targ-19-a097
Subject(s) - multiple drug resistance , pharmacology , potency , linker , brentuximab vedotin , context (archaeology) , chemistry , drug resistance , efflux , cancer research , medicine , biology , in vitro , biochemistry , tumor cells , computer science , paleontology , cd30 , microbiology and biotechnology , operating system